e.l.f. Beauty
ELF NYSE Personal Care Products Financials FY2016βFY2026
e.l.f. Beauty's revenue rose 24.6% to $1.6 billion in fiscal 2026. Its operating margin was 4.5%, down from 12.0% a year earlier. Free cash flow was $190 million, up 64.8%. It paid out $50 million in dividends and buybacks, 26% of free cash flow. The diluted share count rose 1.7%.
What e.l.f. Beauty does
No business description yet.
- Legal name
- e.l.f. Beauty, Inc.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001600033-26-000020
0001600033
Revenue and margins
e.l.f. Beauty had $1.6B of revenue in fiscal 2026, up 24.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $190M in fiscal 2026, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
e.l.f. Beauty returned $50.0M to shareholders in fiscal 2026, 26% of free cash flow. The diluted share count rose 1.7%.
Value e.l.f. Beauty yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$552M and divides by 59.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 114.2x Β· peers 23.4x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably e.l.f. Beauty can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $43.4M | $121M | $108M | $149M | $290M |
| Debt incl. finance leases | $96.9M | $66.5M | $262M | $257M | $842M |
| Net debt / EBITDA | 0.9x | β0.6x | 0.9x | 0.5x | 3.6x |
| Debt / equity | 0.3x | 0.2x | 0.4x | 0.3x | 0.7x |
| Interest coverage | 16.9x | 19.2x | 13.3x | 10.1x | 2.0x |
| Current ratio | 3.0x | 2.8x | 1.6x | 3.1x | 2.4x |
| Quick ratio | 1.7x | 2.1x | 1.0x | 2.0x | 1.7x |
| Total assets | $495M | $596M | $1.1B | $1.2B | $2.4B |
| Total liabilities | $182M | $185M | $487M | $487M | $1.3B |
| Shareholders' equity | $312M | $411M | $643M | $761M | $1.1B |
| Net debt (β = net cash) | $53.5M | β$54.3M | $154M | $108M | $552M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$16.9M
6 insiders
Of sales under plans
98%
$16.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Joshua Allen FranksSVP, Operations | Sold plan | 7,926 | $110.15 | $0.9M | Form 4 |
| Oct 12, 2026 | Joshua Allen FranksSVP, Operations | Sold plan | 8,366 | $110.01 | $0.9M | Form 4 |
| Oct 1, 2026 | Tarang AminChief Executive Officer, Director | Sold plan | 47,000 | $103.31 | $4.9M | Form 4 |
| Sep 8, 2026 | Joshua Allen FranksSVP, Operations | Sold plan | 200 | $110.00 | $0.0M | Form 4 |
| Sep 8, 2026 | Mandy J FieldsSee Remarks | Sold plan | 16,065 | $104.52 | $1.7M | Form 4 |
| Sep 1, 2026 | Joshua Allen FranksSVP, Operations | Sold plan | 5,512 | $110.00 | $0.6M | Form 4 |
| Aug 19, 2026 | Joshua Allen FranksSVP, Operations | Sold plan | 5,718 | $100.00 | $0.6M | Form 4 |
| Aug 18, 2026 | Lauren Cooks LevitanDirector | Sold | 1,034 | $93.15 | $0.1M | Form 4 |
| Aug 4, 2026 | Kory MarchisottoSee Remarks | Sold plan | 12,173 | $88.02 | $1.1M | Form 4 |
| Jul 1, 2026 | Jennifer Catherine HartnettChief Commercial Officer | Sold plan | 25,357 | $80.00 | $2.0M | Form 4 |
| Jul 1, 2026 | Tarang AminChief Executive Officer, Director | Sold plan | 50,164 | $78.24 | $3.9M | Form 4 |
| Jun 9, 2026 | Kory MarchisottoSee Remarks | Sold | 4,352 | $51.53 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 6 / 9 | 4 / 9 |
| Accruals ratio | 6.6% | β1.8% | β10.2% |
| Altman Z'' | 2.46 | 3.92 | 2.18 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| e.l.f. Beauty ELF | $6.8B | 24.6% | 4.5% | 11.6% | 3.8% | 114.2x | 4 | |
| Coty COTY | $2.8B | β1.5% | β1.4% | 6.0% | β1.0% | β | 3 | Compare β |
| EstΓ©e Lauder Companies EL | $39.6B | 5.1% | 5.2% | 8.7% | 4.9% | β | 6 | Compare β |
| Kenvue KVUE | $37.6B | β2.1% | 16.0% | 11.4% | 10.0% | 22.5x | 6 | Compare β |
| Procter & Gamble PG | $387.6B | 3.3% | 22.7% | 17.4% | 20.1% | 24.3x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $230M | $270M | $267M | $283M | $318M | $392M | $579M | $1.0B | $1.3B | $1.6B |
| Gross profit | $132M | $165M | $163M | $181M | $206M | $252M | $390M | $724M | $936M | $1.2B |
| Operating income | $23.1M | $33.3M | $26.2M | $29.9M | $9.4M | $29.8M | $68.1M | $150M | $158M | $73.6M |
| Interest expense | $16.3M | $8.8M | $7.8M | $6.3M | $3.0M | $1.8M | $3.5M | $11.3M | $15.7M | $37.4M |
| Pretax income | $9.8M | $22.5M | $18.0M | $24.1M | $3.7M | $25.4M | $64.1M | $141M | $146M | $40.5M |
| Income tax | $4.5M | β$11.0M | $2.4M | $6.2M | β$2.5M | $3.7M | $2.5M | $13.3M | $33.4M | $14.1M |
| Net income | $5.3M | $33.5M | $15.5M | $17.9M | $6.2M | $21.8M | $61.5M | $128M | $112M | $26.3M |
| Diluted EPS | β$39.47 | $0.68 | $0.32 | $0.35 | $0.12 | $0.41 | $1.11 | $2.21 | $1.92 | $0.44 |
| Diluted shares | 0.01B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $2.1M | $12.4M | $55.6M | $44.3M | $29.5M | $19.5M | $102M | $71.2M | $134M | $213M |
| Capital expenditure | $9.2M | $7.5M | $8.9M | $9.4M | $6.5M | $4.8M | $1.7M | $8.7M | $18.5M | $22.4M |
| Free cash flow | β$7.1M | $4.8M | $46.7M | $34.9M | $23.0M | $14.7M | $100M | $62.5M | $115M | $190M |
| Depreciation and amortization | $13.2M | $14.5M | $17.9M | $22.8M | $25.2M | $27.1M | $17.6M | $30.2M | $44.1M | $79.4M |
| Stock-based compensation | $7.1M | $13.5M | $16.8M | $15.5M | $19.7M | $19.6M | $29.1M | $40.6M | $71.8M | $86.9M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $25.9M | $0.0M | $0.0M | $0.0M | $275M | $0.0M | $582M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $7.9M | $0.0M | $0.0M | $0.0M | $0.0M | $67.1M | $50.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $0.0M | $0.0M | $7.9M | $0.0M | $0.0M | $0.0M | $0.0M | $67.1M | $50.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $15.3M | $10.1M | $51.2M | $46.2M | $57.8M | $43.4M | $121M | $108M | $149M | $290M |
| Total debt | $165M | $156M | $150M | $139M | $127M | $96.9M | $66.5M | $262M | $257M | $842M |
| Finance lease liabilities | $0.0M | $0.0M | $4.0M | $3.0M | $2.2M | $1.4M | $0.6M | $0.1M | $0.0M | $0.0M |
| Current assets | $125M | $124M | $142M | $132M | $170M | $193M | $303M | $477M | $541M | $789M |
| Current liabilities | $80.3M | $51.4M | $43.0M | $51.1M | $73.3M | $65.0M | $108M | $299M | $177M | $336M |
| Inventory | $69.4M | $62.7M | $46.3M | $46.2M | $56.8M | $84.5M | $81.3M | $192M | $187M | $220M |
| Property and equipment, net | $17.2M | $18.0M | $21.8M | $17.2M | $13.8M | $10.6M | $7.9M | $14.0M | $28.8M | $41.5M |
| Total assets | $415M | $417M | $436M | $453M | $487M | $495M | $596M | $1.1B | $1.2B | $2.4B |
| Total liabilities | $274M | $223M | $207M | $211M | $218M | $182M | $185M | $487M | $487M | $1.3B |
| Shareholders' equity | $141M | $194M | $229M | $242M | $270M | $312M | $411M | $643M | $761M | $1.1B |
| Margins | ||||||||||
| Gross margin | 57.6% | 61.0% | 60.9% | 64.0% | 64.8% | 64.2% | 67.4% | 70.7% | 71.2% | 70.7% |
| Operating margin | 10.1% | 12.3% | 9.8% | 10.6% | 3.0% | 7.6% | 11.8% | 14.6% | 12.0% | 4.5% |
| EBITDA margin | 15.8% | 17.7% | 16.5% | 18.7% | 10.9% | 14.5% | 14.8% | 17.6% | 15.4% | 9.4% |
| Net margin | 2.3% | 12.4% | 5.8% | 6.3% | 2.0% | 5.6% | 10.6% | 12.5% | 8.5% | 1.6% |
| FCF margin | β3.1% | 1.8% | 17.5% | 12.3% | 7.2% | 3.8% | 17.3% | 6.1% | 8.8% | 11.6% |
| Returns | ||||||||||
| Return on capital | 6.9% | 10.6% | 6.8% | β | 2.8% | 7.2% | 18.1% | 23.5% | 14.6% | 3.8% |
| Return on capital employed | 7.1% | 9.5% | 6.9% | β | 2.3% | 7.1% | 14.9% | 22.7% | 16.6% | 4.7% |
| Return on equity | 13.2% | 20.0% | 7.3% | β | 2.4% | 7.5% | 17.0% | 24.2% | 16.0% | 2.8% |
| Return on assets | 1.4% | 8.1% | 3.6% | β | 1.3% | 4.4% | 11.3% | 14.8% | 9.4% | 1.5% |
| Growth | ||||||||||
| Revenue growth | 19.9% | 17.6% | β0.9% | β | 12.5% | 23.3% | 47.6% | 76.9% | 28.3% | 24.6% |
| Net income growth | 21.9% | 530.1% | β53.6% | β | β65.2% | 249.3% | 182.6% | 107.5% | β12.2% | β76.5% |
| EPS growth | β | β | β52.9% | β | β65.7% | 241.7% | 170.7% | 99.1% | β13.1% | β77.1% |
| FCF growth | β149.4% | β | 866.3% | β | β34.1% | β36.1% | 581.6% | β37.6% | 84.5% | 64.8% |
| Share count change | β58.7% | 291.7% | β0.2% | β | 2.3% | 3.2% | 3.1% | 4.4% | 1.0% | 1.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.1x | 3.1x | 2.3x | 1.8x | 2.0x | 0.9x | β0.6x | 0.9x | 0.5x | 3.6x |
| Debt / equity | 1.2x | 0.8x | 0.7x | 0.6x | 0.5x | 0.3x | 0.2x | 0.4x | 0.3x | 0.7x |
| Interest coverage | 1.4x | 3.8x | 3.4x | 4.8x | 3.1x | 16.9x | 19.2x | 13.3x | 10.1x | 2.0x |
| Current ratio | 1.6x | 2.4x | 3.3x | 2.6x | 2.3x | 3.0x | 2.8x | 1.6x | 3.1x | 2.4x |
| Quick ratio | 0.7x | 1.2x | 2.2x | 1.7x | 1.6x | 1.7x | 2.1x | 1.0x | 2.0x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.0% | 2.8% | 3.3% | 3.3% | 2.0% | 1.2% | 0.3% | 0.9% | 1.4% | 1.4% |
| Stock comp / revenue | 3.1% | 5.0% | 6.3% | 5.5% | 6.2% | 5.0% | 5.0% | 4.0% | 5.5% | 5.3% |
| Payouts / FCF | β | 0.0% | 0.0% | 22.7% | 0.0% | 0.0% | 0.0% | 0.0% | 58.2% | 26.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 6.0 | β | β | 6.0 | 7.0 | 5.0 | 6.0 | 4.0 |
| Altman Z'' | β2.8 | β1.5 | β0.8 | β0.9 | β0.7 | 0.7 | 3.0 | 2.5 | 3.9 | 2.2 |
| Accruals ratio | 0.8% | 5.1% | β9.4% | β | β4.9% | 0.5% | β7.4% | 6.6% | β1.8% | β10.2% |
Source: SEC EDGAR XBRL filings (CIK 0001600033). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.